Adenoviral gene therapy in gastric cancer: A review
Open Access
- 1 January 2008
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (2), 180-184
- https://doi.org/10.3748/wjg.14.180
Abstract
Gastric cancer is one of the most common malignancies worldwide. With current therapeutic approaches the prognosis of gastric cancer is very poor, as gastric cancer accounts for the second most common cause of death in cancer related deaths. Gastric cancer like almost all other cancers has a molecular genetic basis which relies on disruption in normal cellular regulatory mechanisms regarding cell growth, apoptosis and cell division. Thus novel therapeutic approaches such as gene therapy promise to become the alternative choice of treatment in gastric cancer. In gene therapy, suicide genes, tumor suppressor genes and anti-angiogenesis genes among many others are introduced to cancer cells via vectors. Some of the vectors widely used in gene therapy are Adenoviral vectors. This review provides an update of the new developments in adenoviral cancer gene therapy including strategies for inducing apoptosis, inhibiting metastasis and targeting the cancer cells.Keywords
This publication has 64 references indexed in Scilit:
- Mechanisms of Disease: Helicobacter pylori-related gastric carcinogenesis—implications for chemopreventionNature Clinical Practice Gastroenterology & Hepatology, 2006
- Carcinoembryonic Antigen–Targeted Selective Gene Therapy for Gastric Cancer through FZ33 Fiber-Modified Adenovirus VectorsClinical Cancer Research, 2006
- Cancer occurrence in Iran in 2002, an international perspective.2005
- Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cellsBiochemical and Biophysical Research Communications, 2004
- Potential Applications of Gene Therapy in the Patient with CancerDrugs & Aging, 2000
- Adenovirus-mediated transfer of wild-type p53 gene results in apoptosis or growth arrest in human cultured gastric carcinoma cells.International Journal of Oncology, 1999
- Transduction of Fas gene orBcl-2antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugsWorld Journal of Gastroenterology, 1998
- Current status of gene therapy in gastroenterologyWorld Journal of Gastroenterology, 1998
- Epidemiology of gastric cancer.1996
- The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.1993